COVID-19 vaccine is available through Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA). Find answers to your questions about getting vaccinated for COVID-19.
- Covid-19 Boosters — Where from Here?
INFORMATION, POSTPONEMENTS, & CANCELLATIONS
• Helpful Guidelines for Remote Work – Managers & Employees.
• Any research protocol involving direct clinical benefits (infusions, injections, oral medications) to study participants will continue to be implemented in the GCRU.
• Biostatistics Drop-In Sessions have been canceled until further notice. Please contact Howard Cabral and Janice Weinberg for any statistical questions.
Community Discussion about COVID-19
The importance of engaging our local community in a discussion about COVID-19 became a priority during the pandemic. The existing partnership with three other MA CTSA’s (Tufts, Harvard, UMass) CE Programs, was leveraged to collaboratively organize a recurring COVID-19 Community Forum series.
The COVID-19 Biorepository is an institutional resource available to Boston Medical Center (BMC) and Boston University (BU) researchers interested in biologic samples collected from BMC patients. The goal of the Biorepository is to support innovative and impactful science on the SARS-CoV-2 virus. The Biorepository contains 1) discarded clinical samples from BMC patients (both patients with and without COVID-19), and 2) samples collected from a prospective cohort study of hospitalized BMC COVID-19 patients, with sample collection from ambulatory COVID-19 patient and COVID-19 survivor arms set to begin imminently.
Access to COVID-19 Samples via the MassCPR Sample Sharing System
As many of you know, Boston Medical Center and Boston University are members of the Massachusetts Consortium on Pathogen Readiness (MassCPR). This initiative, led by Harvard Medical School, was convened one year ago with the mission to develop and invest in research projects and infrastructure to address the current global COVID-19 pandemic.
CTSI RESPONSE TO COVID-19 PANDEMIC
Our goal was to accelerate the process of translating COVID-19 lab findings into medical practice and treatments to improve the health and well-being of a diverse patient population.
- Read the BU/BMC COVID-19 Publications
- Live COVID publication dashboard
- See listed clinical studies from ClinicalTrials.gov
- Find articles from PubMed.gov
• Information for NIH Applicants and Recipients of NIH Funding
• Funding Opportunities & Open Notices
• Funding Opportunities Specific to COVID-19
COVID-19 Funding Opportunities
NIH COVID-19 Community Engagement Alliance (CEAL) AGAINST COVID-19 Disparities
CEAL focuses on addressing misinformation around COVID-19, engaging trusted partners and messengers in the delivery of accurate information, and educating communities on the importance of inclusion in clinical research to overcome COVID-19, and most importantly, health disparities.
Clinical trials need people from all age groups, races, ethnicities, and backgrounds. On this website, you can find information about clinical trials you can participate in as well as ways to donate blood and plasma that will lead to prevention and treatment breakthroughs to benefit everyone.
NCATS is generating a collection of datasets by screening a panel of SARS-CoV-2-related assays against all approved drugs. These datasets, as well as the assay protocols used to generate them, are being made immediately available to the scientific community on this site as these screens are completed.
National COVID Cohort Collaborative (N3C)
The N3C is a partnership among the NCATS-supported Clinical and Translational Science Awards (CTSA) Program hubs and the National Center for Data to Health (CD2H)(link is external), with overall stewardship by NCATS. Collaborators will contribute and use COVID-19 clinical data to answer critical research questions to address the pandemic.
N3C Data Enclave
The N3C Data Enclave is a secure platform through which the harmonized clinical data provided by our contributing members is stored. The data itself can only be accessed through a secure cloud portal hosted by NCATS and cannot be downloaded or removed. N3C invites you to begin your journey with the Enclave and join the collaborative efforts of our partners to better understand and address the most pressing COVID-19 clinical questions.
LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive resource on the subject, providing central access to 80588 (and growing) relevant articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access.
Global. health is a massive epidemiological data collection that enables access to 10 million anonymized Covid-19 records from 160 countries. Each record contains up to 40 data points about the case, including demographics, travel history, testing dates, and outcomes. The project was inspired by just a spreadsheet in the pandemic’s earliest days, an effort born when a group of international epidemiologists decided to collect and openly share granular data on individual Covid-19 cases around the world.
NEJM Covid-19 Articles and Resources
A collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
COVID-19 Pandemic Information
Get the latest updates on the COVID-19 response. Stay informed
COVID-19 Treatment Guidelines
COVID-19 & Pregnancy
COVID-19 News Highlights
- Risk for Blood Clots After COVID-19 Vaccination ExploredResearchers Race to Understand Long COVID in National Study
- Researchers Race to Understand Long COVID in National Study
- Omicron wave hospitalized 5 times as many young children as Delta did
- ‘Long COVID’ linked to lasting airways disease
- SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests
- Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19
- FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19
- Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection
- Myocardial injury during COVID-19 hospitalization tied to mortality, long-term symptoms
- Why the coronavirus’s delta variant dominated 2021
- Women, Science, and the Impact of COVID-19
- The Impact of the COVID-19 Pandemic on the Extramural Scientific Workforce – Outcomes from an NIH-Led Survey
- Presence at BU of the B.1.1.7 variant, which first emerged in the UK, is diminishing as COVID clusters come under control on campus
- T cells recognize recent SARS-CoV-2 variants
- Coronavirus (COVID-19) Update: FDA takes steps to streamline the path for COVID-19 screening tools, provides information to help groups establishing testing programs
- BU has begun sequencing COVID samples for variants; two variants that first emerged in South Africa, UK already detected at BU
- Cancer Researchers Bring Tools, Experience to COVID-19 Studies
- Tissue Model Approach Provides Clues to SARS-CoV-2 Brain Infections
- Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19
- SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study Suggests
- Pregnant Women in Third Trimester Unlikely to Pass SARS-CoV-2 Infection to Newborns
- Investigational COVID-19 Therapeutics to be Evaluated in Large Clinical Trials
- A Close-up of COVID-19 in Lung Cells
- The COVID-19 Vaccines: Everything You Need to Know
- NIH observational study of coronavirus infection and multisystem inflammatory syndrome in children begins
- NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FD
- SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention